AstraZeneca's Big Bet: $1.5 Billion Investment in State-of-the-Art Cancer Treatment Hub in Singapore

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC por...

May 20, 2024 | Monday | News
Hepatitis: The silent killer

May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations. Hepatitis is an inf...

May 20, 2024 | Monday | Reports
bioLytical Laboratorieas Launches INSTI® c in Australia, Aiding Hepatitis C Elimination Efforts

bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI He...

May 20, 2024 | Monday | News
InnoCare Pharma Completes Patient Enrollment for Phase II Trial of ICP-488, Advancing Novel Psoriasis Treatment

InnoCare Pharma,  a leading biopharmaceutical company dedicated to revolutionizing the treatment of cancer and autoimmune diseases, proudly announces ...

May 16, 2024 | Thursday | News
QIAGEN Clinical Insight Interpret Earns IVDR Certification for Oncology and Hereditary Applications

As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is appro...

May 16, 2024 | Thursday | News
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity

Genentech, a member of the Roche Group  announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being...

May 16, 2024 | Thursday | News
Atraverse Medical's HOTWIRE™ RF Guidewire Receives FDA Clearance, Revolutionizing Left-Heart Access

Atraverse Medical, a San Diego-based medical device company, announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel devic...

May 15, 2024 | Wednesday | News
BenevolentAI & AstraZeneca Unveil Novel Heart Failure Target

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma ...

May 15, 2024 | Wednesday | News
FogPharma® and ARTBIO Announce Collaboration to Develop Next-Generation Cancer Therapies

FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently availabl...

May 14, 2024 | Tuesday | News
Photocure's Partner Asieris Pharmaceuticals Advances Cevira® for Potential Approval in China

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National...

May 13, 2024 | Monday | News
ArcScan's Insight® 100 Granted NMPA Approval in China, Offering Advanced Solution for Myopia Treatment

ArcScan, Inc., a global medical technology company dedicated to helping ophthalmologists improve vision with ultra-high frequency ultrasound diagnostic ima...

May 13, 2024 | Monday | News
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine

  Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...

May 10, 2024 | Friday | News
Nxera Pharma's Partner, Neurocrine Biosciences, Initiates Phase 1 Study for Promising Investigational Compound, NBI-1117567

Nxera Pharma  notes that its partner Neurocrine Biosciences  a leading neuroscience-focused biopharmaceutical company, announced that it has init...

May 09, 2024 | Thursday | News
MSD Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global materna...

May 09, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close